GENPF (Genix Pharmaceuticals) Days Payable: 0.00 (As of Jan. 2026)


What is Genix Pharmaceuticals Days Payable?

Genix Pharmaceuticals GENPF Days Payable is 0.00 as of Jan. 2026. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Genix Pharmaceuticals ranks worse than 108695.54% on this metric.

Genix Pharmaceuticals's average Accounts Payable for the three months ended in Jan. 2026 was $0.12 Mil. Genix Pharmaceuticals's Cost of Goods Sold for the three months ended in Jan. 2026 was $0.00 Mil.

The historical rank and industry rank for Genix Pharmaceuticals's Days Payable or its related term are showing as below:

During the past 13 years, Genix Pharmaceuticals's highest Days Payable was 24272.50. The lowest was 41.19. And the median was 107.00.

GENPF's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.835
* Ranked among companies with meaningful Days Payable only.

Genix Pharmaceuticals's Days Payable stayed the same from Jan. 2025 (0.00) to Jan. 2026 (0.00). stayed the same

Genix Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Days Payable Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 8,812.14 26,553.75 0.00

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GENPF vs ZTS, UTHR: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genix Pharmaceuticals Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Days Payable falls into.


Genix Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genix Pharmaceuticals's Days Payable for the fiscal year that ended in Oct. 2025 is calculated as

Days Payable (A: Oct. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Oct. 2024 ) + Accounts Payable (A: Oct. 2025 )) / count ) / Cost of Goods Sold (A: Oct. 2025 )*Days in Period
=( (0.109 + 0.116) / 2 ) / 0*365
=0.1125 / 0*365
=N/A

Genix Pharmaceuticals's Days Payable for the quarter that ended in Jan. 2026 is calculated as:

Days Payable (Q: Jan. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Oct. 2025 ) + Accounts Payable (Q: Jan. 2026 )) / count ) / Cost of Goods Sold (Q: Jan. 2026 )*Days in Period
=( (0.116 + 0.129) / 2 ) / 0*365 / 4
=0.1225 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Genix Pharmaceuticals (GENPF) has a Days Payable of 0.00 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genix Pharmaceuticals and its competitors. Over the past decade, Genix Pharmaceuticals' Days Payable has ranged from 41.19 to 24,272.50. According to the industry distribution chart, Genix Pharmaceuticals ranks #999999 out of 920 companies in the Drug Manufacturers industry.
Is Genix Pharmaceuticals' Days Payable too high?
Genix Pharmaceuticals' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 41.19 to a high of 24,272.50. Based on the distribution chart, Genix Pharmaceuticals ranks #999999 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Genix Pharmaceuticals' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genix Pharmaceuticals ranks #999999 out of 920 companies for Days Payable. This places Genix Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 90.84. Historically, Genix Pharmaceuticals' own Days Payable has ranged from 41.19 to 24,272.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genix Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genix Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Days Payable is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.